Clinical trial
Rhodiola Rosea Therapy of Major Depressive Disorder
NCT01098318 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rhodiola Rosea Therapy of Major Depressive Disorder
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- July 31, 2013
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression